1. Xofluza, the first new treatment for the flu in nearly two decades, was approved to treat acute uncomplicated flu in patients 12 years or older who have had flu symptoms for no more than 48 hours.
2. PicoAMH Elisa is a diagnostic test that can help determine a patient’s menopausal status.
3. Dupixent is a maintenance therapy for asthma patients 12 years or older with an eosinophilic phenotype or those who are dependent on corticosteroids.
4. Khapazory, a chemotherapy protective drug, is approved to diminish the toxicity associated with overdosage of folic acid antagonists and rescue after high-dose methotrexate therapy.
5. Medtronic received the greenlight for its Valiant Navion thoracic stent graft, a minimally invasive system that corrects lesions in the descending thoracic aorta.
More articles on supply chain:
Medline secures 2 new distributor partnerships
Express Scripts to expand network offerings to mail order pharmacies: 5 things to know
Hospitals could save $25.4B annually in supply chain costs, study finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.